NEW YORK, Oct. 28 - Caliper Technologies, Ambion, and an unnamed third party will use a $1.6 million NIH grant to develop an automated microfluidics-based RNA-amplification technology, the firms said today.
According to the companies, the proposed system will include a Caliper microfluidic LabChip product and a reagent kit made by Ambion to amplify reactions on the LabChip.
Caliper scientists will develop the chip while Ambion will develop the assay and tweak reagents. It was not immediately clear how long the R&D will take. Both companies together with the third party will pitch in to build the instrument.
The companies said they hope the new technology will increase throughput, decrease sample requirements, and boost consistency associated with RNA amplification.
The firms will use a $1.6 SBIR grant awarded to privately held Ambion by the NIH's National Institute of General Medical Sciences.